Jonathan Golas

1.6k total citations · 1 hit paper
8 papers, 1.1k citations indexed

About

Jonathan Golas is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jonathan Golas has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Jonathan Golas's work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Cell Adhesion Molecules Research (2 papers). Jonathan Golas is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (3 papers) and Cell Adhesion Molecules Research (2 papers). Jonathan Golas collaborates with scholars based in United States and China. Jonathan Golas's co-authors include Carolyn Discafani, Ramaswamy Nilakantan, Allan Wissner, Yu‐Fen Wang, M. Brawner Floyd, Sridhar K. Rabindran, Bernard D. Johnson, Ru Shen, Hwei‐Ru Tsou and William Hallett and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Jonathan Golas

8 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase

2004 503 citations Sridhar K. Rabindran, Carolyn Discafani et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Golas United States	6	818	438	311	305	194	8	1.1k
Glenn Spehar United States	7	806 1.0×	499 1.1×	340 1.1×	234 0.8×	131 0.7×	8	1.2k
Christoph A. Schatz Germany	15	525 0.6×	503 1.1×	375 1.2×	346 1.1×	108 0.6×	47	1.2k
Jennifer Vermette United States	8	712 0.9×	334 0.8×	304 1.0×	305 1.0×	49 0.3×	14	964
Haitian Quan China	17	662 0.8×	492 1.1×	115 0.4×	383 1.3×	188 1.0×	30	1.3k
Martina Uttenreuther‐Fischer Germany	16	890 1.1×	350 0.8×	214 0.7×	666 2.2×	90 0.5×	32	1.1k
Brenda J Curry United Kingdom	7	768 0.9×	814 1.9×	150 0.5×	490 1.6×	243 1.3×	8	1.5k
Christine Powell United States	8	892 1.1×	455 1.0×	289 0.9×	540 1.8×	127 0.7×	15	1.4k
G Pomatico Italy	9	1.0k 1.2×	601 1.4×	179 0.6×	630 2.1×	49 0.3×	10	1.4k
Guorong Yang China	8	611 0.7×	369 0.8×	269 0.9×	181 0.6×	38 0.2×	19	920
Rama Krishna Kancha India	14	365 0.4×	286 0.7×	71 0.2×	304 1.0×	114 0.6×	37	761

Countries citing papers authored by Jonathan Golas

Since Specialization

Citations

This map shows the geographic impact of Jonathan Golas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Golas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Golas more than expected).

Fields of papers citing papers by Jonathan Golas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Golas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Golas. The network helps show where Jonathan Golas may publish in the future.

Co-authorship network of co-authors of Jonathan Golas

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Golas. A scholar is included among the top collaborators of Jonathan Golas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Golas. Jonathan Golas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Tan, Xingzhi, Wei Fang, Stephanie Bisulco, et al.. (2020). Abstract A16: A GUCY2c-CD3 bispecific engages T cells to induce cytotoxicity in gastrointestinal tumors. Cancer Immunology Research. 8(3_Supplement). A16–A16. 1 indexed citations

2.

Ji, Changhua, Marc D. Roy, Jonathan Golas, et al.. (2019). Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors. Clinical Cancer Research. 25(15). 4735–4748. 91 indexed citations

3.

Sung, Matthew, Xingzhi Tan, Bingwen Lu, et al.. (2017). Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1). Molecular Cancer Therapeutics. 17(1). 243–253. 155 indexed citations

4.

Fisher, Timothy S., Andrea T. Hooper, Justin Lucas, et al.. (2017). A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice. Cancer Immunology Immunotherapy. 67(2). 247–259. 31 indexed citations

5.

Geles, Kenneth G., Yijie Gao, Latha Sridharan, et al.. (2015). Abstract 1697: Therapeutic targeting the NOTCH3 receptor with antibody drug conjugates. Cancer Research. 75(15_Supplement). 1697–1697. 5 indexed citations

6.

Tsou, Hwei‐Ru, William Hallett, Marvin F. Reich, et al.. (2005). Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity. Journal of Medicinal Chemistry. 48(4). 1107–1131. 246 indexed citations

7.

Golas, Jennifer M., Judy Lucas, Jonathan Golas, et al.. (2005). SKI-606, a Src/Abl Inhibitor withIn vivoActivity in Colon Tumor Xenograft Models. Cancer Research. 65(12). 5358–5364. 115 indexed citations

8.

Rabindran, Sridhar K., Carolyn Discafani, Edward Rosfjord, et al.. (2004). Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase. Cancer Research. 64(11). 3958–3965. 503 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact